verekitug
verekitug: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Upstream Bio, Inc. (UPB) | Phase 2 |
Clinical Trials (1)
A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess Efficacy and Safety of Verekitug (UPB-101) in Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Frequently asked questions
Who is developing verekitug?
verekitug is being developed by Upstream Bio, Inc..
How many clinical trials involve verekitug?
BioSniper tracks 1 clinical trial involving verekitug.
Get deeper analysis on verekitug
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis